June 12, 2025

• The Trump administration is rushing to rehire thousands of federal workers it previously dismissed after service disruptions and court rulings forced agencies like the FDA and IRS to reverse staff cuts.
  • Efforts also include bringing back experienced staff who took voluntary buyouts and early retirements to address major experience gaps.
• Jim O’Neill was sworn in as Deputy Secretary of HHS on June 9, 2025. He previously held HHS leadership roles during the G.W. Bush presidency. He will help oversee agency operations and lead innovation efforts focused on AI, emerging technologies, and system modernization.
• HHS announced Paula M. Stannard as Director of the Office for Civil Rights, who most recently served as Chief Legal Counsel of the Montana Department of Public Health and Human Services. She will be charged with enforcing HIPAA as well as civil rights protections.
• Congressional updates:
  • NIH Director Jay Bhattacharya faced questions about the Trump administration’s proposed $18B budget cut to the agency during a Senate hearing on June 10. Democratic lawmakers raised concerns about canceled clinical trials and the politicization of science.
  • A House Subcommittee advanced the Trump administration’s proposed 2026 budget for the FDA, cutting funding by $300M compared to last year. The full House Appropriations Committee met on Wednesday, June 11, to hold its markup of the bill.
  • The U.S. House Oversight and Government Reform Committee held a hearing on Tuesday, June 10, about privacy and national security concerns related to 23andMe’s bankruptcy sale.
    • 23andMe’s interim CEO also faced privacy-related questions from the Senate Judiciary Committee, with members asking if any of the genetic data tested by Labcorp was breached, in a hearing on Wednesday, June 11.
  • The House Energy and Commerce Subcommittee on Health held a hearing on Wednesday, June 11, to examine health care supply chain challenges and consider regulatory modernization efforts that would ensure sustainable access to safe medicines.

GENERAL NEWS

• The NIH issued a request for information (RFI) asking for industry input on a new, institute-wide AI strategy and one-year action plan. Specifically, the RFI asks how to move from current data-driven analytics to fully autonomous, self-documenting biomedical AI tools. Comments are due by July 15, 2025.
• On Thursday, June 5, the House Oversight Committee held a hearing to examine the federal government’s approach to AI. During the hearing, members discussed the 10-year moratorium on states enforcing AI laws in the House-passed reconciliation bill.
  • Adam Thierer, Senior Research Fellow at the R Street Institute, explained that the moratorium is tied to a section of the bill that allocates funding to modernize the Department of Commerce’s technology systems and is designed to prevent a patchwork of conflicting state regulations from undermining national efforts. Rep. Clay Higgins (R-LA) clarified that the moratorium does not prevent states from considering or enacting AI-specific legislation. Rather, it asks states to refrain from enforcing new AI laws and recognize that AI is, by nature, interstate commerce.
• The FDA said it will use AI to “radically increase efficiency” across several initiatives, including accelerating new drug and medical device approvals and food ingredient reviews in a JAMA article.
• On June 11, The Joint Commission and the Coalition for Health AI (CHAI) announced a partnership to accelerate the development and adoption of health AI best practices and guidance.
• The first group of healthcare organizations in Duke’s Health AI Partnership (HAIP) peer-learning program, created to help under-resourced healthcare organizations understand and manage long-term AI use, implemented ambient scribes and is sharing best practices on incorporating AI into daily clinical care routines.
  • In July, HAIP’s Mark Sendak will be speaking at a HIMSS in-person event in NYC on the Future of AI.
• A global survey of patients across 74 hospitals found limited trust for AI in providing information related to treatment responses. The majority of patients preferred explainable AI systems and physician-led decisions, even if keeping a human in the loop compromised the accuracy of that decision.
• In its annual ‘State of U.S. Nursing & Technicians Report,’ Incredible Health found that 85% of nurses want more AI training, though some remain concerned about impacts on patient-provider relationships.
• Microsoft plans to add a “safety” category to its Azure Foundry AI model leaderboard, helping cloud customers evaluate the security of AI products according to quality, cost, and output speed.
• Meta is considering a $14B investment in the data-labeling startup Scale AI, which would be one of its largest outside investments.

ADMINISTRATIVE APPLICATIONS

• Stanford Medicine is piloting ChatEHR, an AI software designed to summarize patient charts and pull specific data points from EMRs to answer clinical questions, mirroring the capabilities of ChatGPT and other integrated LLMs.
• Vim partnered with ForeSee Medical to integrate AI-based risk adjustment tools into EHR workflows, helping providers identify Hierarchical Condition Categories.
• Vouched, an AI-powered identity verification platform, was approved for integration with the EPIC Toolbox, enabling providers to automate patient identity checks and reduce time spent on manual intake processes.
• Mayo Clinic partnered with ai, an AI-integrated virtual care platform, to leverage ambient documentation and digital tools in proactive care and hospital-at-home services. Mayo Clinic also became an investor in the company’s recent funding round.

CLINICAL APPLICATIONS

• AstraZeneca’s rare disease unit partnered with UK-based health tech startup Pangaea Data, which scaled its AI platform for hard-to-diagnose diseases in 2023 with Microsoft Azure. The new partnership will focus on developing and applying for regulatory approval of an AI clinical decision support system (AI-CDSS) for early detection of hypophosphatasia, a rare metabolic disorder.
• CIVIE launched RadPod, an AI-enabled platform that allows radiologists to interpret medical imaging remotely. The platform includes tools to support workflow efficiency, such as voice recognition, automated quality checks, and real-time payment.
• Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, received its New York State lab permit.
• RadNet acquired See-Mode Technologies, developer of an FDA-approved ultrasound AI for thyroid nodule and breast lesion imaging, expanding subsidiary DeepHealth’s portfolio of AI-powered screening tools.
• Perimeter Medical Imaging launched a database of previous surgical cases that provides real-time, high-resolution tissue imaging and margin measurements to support surgical decisions.
• A recent study examining the use of four leading LLMs (including Gemini, ChatGPT, and Claude) in psychiatric diagnosis and treatment planning found that models recommended lower-quality psychiatric treatments when patient race was implicitly or explicitly indicated, reinforcing concerns that LLMs can perpetuate racial disparities in clinical care.

RESEARCH APPLICATIONS (Drug Discovery, etc.)

• Komodo Health launched its full-stack analytics platform for healthcare and life sciences companies called MapLab Enterprise.
• IQVIA announced custom-built AI agents at NVIDIA’s GTC 2025 AI Conference in Paris, designed to simplify life sciences operations such as target identification and clinical data review.
• ai, an AI research platform used by NYC’s Department of Health, partnered with real-world data provider HealthVerity, expanding pharmaceutical, biotech, and public health researchers’ access to de-identified patient records.
• The Lieber Institute for Brain Development will migrate its IT infrastructure to AWS, expand the use of generative and predictive AI in drug discovery and development for brain disorders.

GENERAL NEWS

• Omada Health—a virtual diabetes and weight management company—raised $150M for its IPO at a valuation of $1.1B. The company’s valuation signals a potential resurgence in the digital health market, following the Hinge Health IPO last month (see here, here).
• Nourish, a virtual nutrition counseling company valued at over $1B earlier this year, added AI-powered features—including meal logging, a scribe tool, and provider-facing nutrition summaries—designed to surface actionable insights for nutrition-related care.
• Berry Fertility, a fertility patient management platform, launched new tools for personalized treatment, medication management, comprehensive tracking, and educational resources.

TELEHEALTH

• CRH Medical Corporation, a gastrointestinal-focused subsidiary of WELL Health Technologies, partnered with virtual specialty care platform WovenX to deliver integrated practice solutions that improve patient access and operational capacity.

REMOTE PATIENT MONITORING

• Tandem Diabetes Care announced an agreement to integrate its insulin delivery systems into Abbott’s upcoming dual glucose-ketone sensor, enabling early detection of diabetic ketoacidosis.
• Sleep Cycle initiated a clinical study in Australia to validate its AI-powered smartphone feature for screening obstructive sleep apnea without wearables or sensors. The company has also completed pre-submission dialogue with the FDA.

MOVING CARE HOME

• Lucet, a behavioral health company, acquired Emcara Health—a value-based provider delivering at-home care—to expand integrated offerings for physical and behavioral health management.
• Ultrahuman—a health monitoring company—launched Ultrahuman Home, a new indoor home health device that allows users to fine-tune environmental factors such as air quality and light to support sleep, cognition, and overall well-being.

FEDERAL NEWS

• The VA is currently using AI in 100+ use cases, including risk scoring for risk of suicide and a ChatGPT for VA employees and clinicians, according to Charles Washington, the VA’s CAIO and CTO, in a Healthcare IT News.

INDUSTRY NEWS

• Alexandra Mugge, formerly CMS Chief Health Informatics Officer, left the agency after more than fifteen years to join Oracle, according to a report from InsideHealthPolicy.
• TeleTracking Technologies, an integrated healthcare operations platform, is partnering its Operations IQ product with Palantir’s AI-powered Foundry and AIP systems. The collaboration intends to optimize staffing, forecast demand, and improve patient flow for health systems.
• Altera Digital Health is joining Health Gorilla’s QHIN through TEFCA, giving Altera’s EHR access to long-term records directly within workflows and optimizing clinical decision-making processes.
• MD Anderson Cancer Center is developing an AI-powered tool with Healthex, a data rights management platform, to streamline the data consent process and help patients understand how their data advances research.
• PointClickCare filed a renewed motion to dismiss Real Time Medical System’s (RTMS) lawsuit accusing the EHR company of information blocking, claiming RTMS’ suit is based on faulty claims and a misinterpretation of the law.
• Pangea Data will partner with Alexion to develop an Artificial Intelligence Clinical Data Support System (AI-CDSS), improving the detection of hypophosphatasia—a rare genetic disease impairing bone and teeth mineralization—based on EHR records.
• Data from more than 5,000 U.S. hospitals revealed that, on average, hospitals spend about 2.29% of their total operating budget on IT operating expenses, or about $9.51M.

DATA PRIVACY AND SECURITY

• The Trump administration issued an Executive Order (EO) to strengthen cybersecurity measures, replacing the Biden administration’s EO on the same topic. Key differences include eliminating mandatory software security compliance attestations and focusing on AI vulnerabilities and containment.
• Ohio-based Kettering Health restored access to its online patient portal MyChart three weeks after the ransomware attack on May 20. According to a recent report, the health system believes that ransomware group Interlock is responsible for the attack.
• The FBI and CISA issued an advisory warning of the Play ransomware group’s actions and tactics, which have affected more than 900 people to date.
• Emails remain the most vulnerable and underfunded healthcare cybersecurity weakness despite confidence expressed by health IT leaders to prevent email-based breaches, according to a new Paubox report. Overdependence on manual safeguards in outdated systems leads to frequent protocol bypass, reflecting a need for more automated email encryption solutions.

GENERAL INVESTMENTS

• Rapid AI startup growth with high valuations reveals greater investment risk due to immature operational infrastructure, making investors’ confidence in founders’ adaptability crucial, according to CapitalG Partner Jill Chase.
• Paytient received $40M from Trinity Capital to expand its financing services nationwide for employers and insurers looking toward affordable out-of-pocket cost smoothing solutions.

AI INVESTMENTS

• Canid, the developer of an AI-powered pediatric vaccine management platform, secured $10M in Series A funding.
• GuideHealth, an AI-driven value-based care provider, secured a $10M investment from Emory Healthcare.

DIGITAL HEALTH INVESTMENTS

• Somnee, an AI-powered sleep technology company, raised $10M in a seed extension round led by Khosla Ventures to launch its next-gen SmartSleep AI system—an EEG-enabled headband that maps brain activity and uses real-time, personalized stimulation to improve sleep.
• MyLaurel, a telehealth-enabled medical group focusing on home-based acute and transitional care, raised $12M to scale its Acute Care at Home program with Oschner Health and expand to new markets.
• Clara Home Care, a startup focused on improving senior caregiver hiring, received $3.1M in seed funding from several investors including Y Combinator. The company employs AI to match families with caregivers and simplify administrative tasks such as scheduling and payroll.
• Salvo Health, a digital company focused on gastrointestinal health, received $4M in extended seed funding to expand its workforce and care coordination technology.

GENERAL NEWS

• Cigna and CVS Health reached a settlement for undisclosed amount about the former Express Scripts president, Amy Bricker, leaving the Cigna PBM in violation of her noncompete agreement to become CVS’ EVP and chief product officer.

HEALTHCARE TRANSPARENCY

• The 5th Circuit Court of Appeals agreed to rehear a case from the Texas Medical Association, that challenged how qualifying payment amounts (QPA) are determined under the No Surprises Act. This means courts will vacate the previous decision reinforcing HHS’ calculation for the QPA used in dispute resolutions for surprise out-of-network bills. It will also give providers another chance to argue that current QPA calculation favors insurers.

DRUG PRICING

• On the heels of last month’s executive order directive to align drug prices with other countries’ in a “most-favored nation” plan, and a subsequent HHS announcement, U.S. Senate health committee Chair Bill Cassidy (R-La.) is reportedly circulating a proposed bill that would link U.S. drug prices to those in other countries.
• The FTC, Justice Department, HHS and the Department of Commerce are hosting listening sessions to discuss ways to make prescription drugs more affordable for Americans by promoting competition:
  • June 30 at 2 pm ET– Anticompetitive Conduct by Pharmaceutical Companies Impeding Generic or Biosimilar Competition
  • July 24 at 2 pm ET– Formulary and Benefit Practices and Regulatory Abuse Impacting Drug Competition
  • August 4 at 2 pm ET– Turning Insights into Action to Reduce Drug Prices
• PCMA, a trade association representing PBMs, and Navitus Health Solutions, joined Caremark and Express Scripts in suing Arkansas over its new law banning PBMs from owning pharmacies.
  • They argue the law would force dozens of pharmacies to close, restrict home delivery, and violate federal law.
• GoodRx launched Community Link, an option that allows independent pharmacies to directly contract with them, bypassing PBMs and providing access to cost-plus pricing.
• Serve You Rx, an alternative PBM, is adding two Stelara biosimilars—Otulfi and Yesintek—to its specialty formulary through a partnership with Waltz Health. This offers members significant savings and simpler access, with support from copay assistance and Waltz’s AI-powered pharmacy platform.

PAYERS

• U.S. Senators are considering adding a provision to the House-passed budget bill that limits the payments Medicare Advantage (MA) plans can receive related to diagnosis codes recorded during at-home risk assessments and chart reviews. This move, which would address “upcoding,” or the practice of inflating diagnosis codes to make beneficiaries seem sicker than they are to receive higher payments, is being considered to reduce federal budget spending.
  • Both UnitedHealth Group and Humana are supporting the provisions, whereas AHIP opposed
• Democratic governors Gavin Newsom of California, JB Pritzker of Illinois, and Tim Walz of Minnesota are planning to roll back state-funded health care for undocumented immigrants.
• A federal judge denied MultiPlan (now Claritev) and its insurer codefendants’ motion to dismiss antitrust and consumer protection claims alleging the companies colluded to suppress provider reimbursement rates.
• Nebraska passed a new prior authorization reform law requiring insurers to make prior auth requirements public, use a standard prior auth form no longer than two pages, and make decisions during specific timeframes. It also prohibits prior auth denials based solely on AI-driven algorithms and mandates physician reviews. The law takes effect January 1, 2026.
• Coventry Health and Life Insurance Company, an Aetna subsidiary, received an estimated $6.9M in MA overpayments in 2018 and 2019, according to an HHS Office of Inspector General audit. The agency urged the payer to repay the funds and improve compliance, but Coventry disputed some of the findings and all recommendations.
• UnitedHealth Group filed a defamation lawsuit against The Guardian, alleging its article used doctored documents and misleading anecdotes to falsely claim the company paid nursing homes to reduce hospital transfers. UHG’s stocks fell after the article was published on May 21.
• A group of state ACA exchange directors sent a letter to Senate leaders, urging them to extend ACA premium tax credits scheduled to expire at the end of 2025 and to address concerns that the reconciliation bill, if passed, would lead to higher costs and increased uninsured rates.
• Insufficient data on MA supplemental benefits hinders efforts to evaluate their value to enrollees and taxpayers, according to a Health Affairs Forefront blog post by KFF staff. Recent CMS reporting requirements could fill these gaps, but usage and spending data remain unavailable.

PROVIDERS

• The AMA swore in Bobby Mukkamala, MD as its 180^th President during its Annual Meeting of the House of Delegates. During his inauguration speech, Dr. Mukkamala spoke about his recent brain tumor diagnosis, concerns over biomedical research funding cuts, and support for federal insurance programs.
  • The AMA elected Willie Underwood III, MD, MSc, MPH, a New York-based urologist, as its President-Elect. More here.
  • As we reported a few weeks ago, the AMA also has a new CEO, John Whyte, MD.
• Also at its Annual Meeting, the AMA adopted public health policies related to alcohol and ultraprocessed foods, guardrails around the collection of physicians’ personal data to improve workplace wellbeing, and guidance for physicians considering entering into a relationship with a corporate entity.
• HHS Secretary Kennedy removed all 17 sitting members of the Advisory Committee on Immunization Practices (ACIP), an independent committee established by Congress to advise the CDC on vaccine safety, efficacy, and clinical use. He replaced them with eight new members, several of whom have a history of expressing anti-vaccine sentiment or voicing concerns about COVID-19 or mRNA vaccines. Secretary Kennedy described the move as a “clean sweep” necessary to restore public trust in science in a Wall Street Journal op-ed. The next ACIP meeting is June 25-27.
  • The AMA passed an emergency resolution that asks Secretary Kennedy to reinstate the dismissed committee members and calls on the U.S. Senate to investigate his decision.
  • More than half of the 258 randomized and placebo-controlled vaccine clinical trials in Stanford’s crowdsourced vaccine research platform included inert placebos, contradicting Kennedy’s statements at a May 14 Senate HELP hearing. Stanford launched the project in April to clarify how vaccines are tested.
• The U.S. Government Accountability Office (GAO) said HHS needs a coordinated, national strategy for diagnostic testing to monitor and respond to infectious disease threats. GAO outlined four key recommendations to improve diagnostic testing and establish a national testing forum in its 220-page report.
• Over 300 NIH employees outlined concerns about Trump administration policies impacting biomedical research and Director Jay Bhattacharya’s stated commitment to scientific dissent. In a letter titled the “Bethesda Declaration,” a nod to Bhattacharya’s 2020 “Great Barrington Declaration” that criticized vaccine mandates, employees described actions that undermine the NIH’s mission to protect the health of Americans.
  • Several Nobel laureates and recognized scientists co-signed a letter of support.
• The Administration for a Healthy America requested $20.6B for FY 2026 in its budget outline to Congress, that included the elimination of several CDC programs, including ones for obesity, heart disease, diabetes, and cancer prevention, along with the agency’s National Center for Chronic Disease Prevention and Health Promotion.
• Former FDA and HHS officials raised concerns about the procedural aspects of the FDA’s review for Novavax’s COVID-19 vaccine, including public statements about how vaccines are approved and delayed regulatory action, which they claim depart from traditional agency practices.
  • In a JAMA viewpoint article, the authors warned that the impact of political appointees in regulatory decision-making could undermine broader vaccine policy and deter long-term investment by introducing unpredictable approval standards.
• President Trump’s executive order to restore gold standard science,which directs agencies to publicize the scientific data informing public policy decisions, could roll back evidence-based health protections, according to a STAT op-ed by SciLight founder Jacob Carter and  Union of Concerned Scientists CEO Gretchen Goldman.
• A federal judge ruled that HHS and the Equal Employment Opportunity Commission cannot require providers, plans, or employers to deliver or cover gender-affirming care if it violates religious beliefs. The Trump administration is unlikely to appeal the decision about the Biden-era rule.
• Chip Kahn will retire as CEO of the Federation of American Hospitals at the end of 2025 after 24 years leading the organization.
• The operators of a Florida-based substance use disorder treatment clinic, Evoke Wellness, have agreed to pay $1.9 million, settling FTC’s allegations that they used deceptive Google search ads and telemarketing to impersonate other treatment providers.
• Hospital operating revenue rose in early 2025 compared to same period in 2024 with improved patient volume and efficiency, according to a Kaufman Hall
• Hospital charity care policies vary widely, with eligibility thresholds ranging from 100% to 600% of the federal poverty level, according to a new Lown Institute report. The Institute urged for federal standards to reduce discrepancies between hospitals’ practices, which can cause unpredictability for patients.

PAYERS AND PROVIDERS (M&A)

• UnitedHealth Group is considering a $1B sale of its Latin American business, including its subsidiary, Banmédica. The potential exit follows a $7.1B loss from its Brazil exit and reflects a broader strategy to refocus on U.S. operations amid ongoing financial challenges.

VALUE-BASED CARE

• A study in the journal Health Affairs Scholar found that value-based care models may improve access to primary care for Medicare patients. Physicians in a full-risk, supported value-based care model accepted more new traditional Medicare patients and kept their panels open longer compared with those in fee-for-service models.

MEDICAID

• As Congress considers Medicaid work requirements, insurers are pushing to lift a ban from 1991 that restricts texting and outreach to enrollees. Advocates argue this ban will complicate efforts to verify eligibility, complete renewals, and help people stay covered.
• The American Public Health Association, along with 65 other public health scholars, is urging HHS to reject Georgia’s request to extend Medicaid work requirements in public comments, arguing the policy raises costs and limits coverage without boosting employment.

REPRODUCTIVE HEALTH

• Attorneys general from four Democratic states requested the FDA to lift restrictions on the abortion pill mifepristone. The petition challenges a planned safety review ordered by HHS Secretary Kennedy, arguing existing data over the past 25 years confirms the drug’s safety.

HEALTH EQUITY & SDOH

• Nurses cite high workloads, staffing shortages, and financial misalignment as major barriers to delivering equitable care to disadvantaged patients, according to a new JAMA Network Open study. Nurses also pointed to bias, language barriers, and gaps in cultural competency training, but noted technology tools and community partnerships can be important supports in addressing these gaps.